tirzepatide for ckd kidneys 🧬 New data from the SUMMIT trial reveals that long-term tirzepatide (Zepbound) may Exciting Developments in Kidney Disease:

Researchers should account for this when designing protocols that measure activity levels or energy expenditure

Your appetite is already significantly reduced, and restricting your eating window further makes it nearly impossible to consume adequate protein and micronutrients

Or if you just like having a warm beverage as part of your routine, you can also try apple cider or hot chocolate

Tirzepatide reduced energy intake compared with placebo (mean difference 429 kcal/day [95% CI 852 to 5 kcal/day]

The slightly higher serious adverse event rate with tirzepatide in SURPASS-2 has not raised safety concerns in subsequent, larger trials